Egalite Biotics Profile
Key Indicators
- Authorised Capital ₹ 0.95 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth -15.77%
- Profit Growth -17.24%
- Ebitda 15.55%
- Net Worth 20.13%
- Total Assets -37.14%
About Egalite Biotics
Egalite Biotics Private Limited (EBPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 February 2012 and has a history of 12 years and 11 months. Its registered office is in Kozhikode, Kerala, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.95 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kolavantakath Das, Koloth Salil, Sreeju, and One other member serve as directors at the Company.
Company Details
-
Location
Kozhikode, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51397KL2012PTC030495
-
Company No.
030495
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Feb 2012
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Egalite Biotics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Koloth Salil
|
Managing Director | 09-Feb-2012 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Kolavantakath Das
|
Director | 09-Feb-2012 | Current |
|
Sreeju
|
Director | 09-Feb-2012 | Current |
|
Jayaraj Sahadevan
|
Additional Director | 05-Jul-2012 | Current |
Financial Performance of Egalite Biotics.
Egalite Biotics Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 15.77% decrease. The company also saw a substantial fall in profitability, with a 17.24% decrease in profit. The company's net worth Soared by an impressive increase of 20.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Egalite Biotics?
In 2017, Egalite Biotics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
On Spot Logistics Private LimitedKoloth Salil is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Egalite Biotics?
Unlock and access historical data on people associated with Egalite Biotics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Egalite Biotics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Egalite Biotics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
